EGF and ovarian carcinoma: To determine whether cPLA2 is essential for producing PAF stimulated by EGF in ovarian cancer cells, we first tested for the effects of arachidonyl trifluoromethyl ketone (AACOCF3), a small-molecular inhibitor of cPLA2[24,25] on PAF production.